Uncategorized

Still Here!

Is it really July 21st already?  The summer is flying by and we’ll be back in school looking at Fall before you know it.  I wanted to post a few interesting tidbits for medication dispensing clinics looking at fall medication orders.  Back to school will soon be upon us as well as  another exciting cold & flu season.

Newly approved generic pharmaceuticals:

LEVONORGESTREL TABS (PLAN B) – approved for Watson in June
PRILOSEC OTC DR CAPS – approved for Dr. Reddy’s in June
ORTHO TRI CYCLIN LO – approved for Barr in June
KENALOG 10 AND KENALOG 40 – approved for Sandoz in May and June

Though prices won’t drop immediately, as new generics get into the market, prices will slowly begin to come down.  Feel free to call PCA at 800.722.0772 to check on any specific products.

Some antibiotic products are still a bit high as the market recovers from recalls and product discontinuations.  We are keeping our eye on these products and will continue to advise our clinic partners on their options.  The good news is that the FDA has recently approved the 2009-2010 flu vaccine and they expect to have an H1N1 vaccine by fall.

Student health centers evaluating fall ordering are invited to contact PCA Pharmaceuticals for a comparative price quotation.  PCA is your partner for all of your clinic dispensing needs.

Schedule a free claims analysis now.

Let’s Talk now

TONY PURKEY JOINS NORTHWIND AS SENIOR VICE PRESIDENT, CLIENT STRATEGIES

Betsy Bigler | Mar 7th, 2024
INDIANAPOLIS, March 7, 2024 – Northwind has announced the addition of Tony Purkey as Senior Vice President, Client Strategies. “Demand from our self-funded employer and union clients is driving rapid growth,” said Phillip Berry, CEO. “Tony Purkey joins Northwind at a time when we need high-integrity leaders with expert knowledge in employer-sponsored health and the … more »

continue reading

Voices Lost in the Noise

Phillip Berry | Jan 31st, 2024
In the health benefits world, the mad scramble toward January renewals/starts has subsided and attention has turned to the annual cycle of review necessary to gauge progress. How did we do? The plan review process generally centers on analytics to gauge progress or regress and to identify “areas of opportunity.” Good. The right data with … more »

continue reading